Of the 57 million people dying worldwide each year, 6 million deaths are caused by cancer and 3 million from HIV/AIDS, with the majority of both occurring in developing countries. These figures indicate the large number of people experiencing incapacitation and pain through shortness of breath, constipation, diarrhoea, nausea as well as distress, depression and anxiety.
Approximately 4.4 percent of US adults may have some form of bipolar disorder during some point in their lifetime, including about 2.4 percent with a “sub-threshold” condition, according to an article in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
The likelihood of developing bipolar disorder depends in part on the combined, small effects of variations in many different genes in the brain, none of which is powerful enough to cause the disease by itself, a new study shows. However, targeting the enzyme produced by one of these genes could lead to development of new, more effective medications.
Scientists have developed a novel strategy for tackling neurodegenerative diseases such as Huntington’s disease: encouraging an individual’s own cells to “eat” the malformed proteins that lead to the disease.
Parkinson’s disease is well-known for its progression of motor disorders: stiffness, slowness, tremors, difficulties walking and talking. Less well known is that Parkinson’s shares other symptoms with narcolepsy, a sleep disorder characterized by sudden and uncontrollable episodes of deep sleep, severe fatigue and general sleep disorder.
Approximately 10.3 percent of U.S. adults appear to have problems with drug use or abuse during their lives, including 2.6 percent who become drug dependent at some point, according to a report in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Pharmaceuticals to update the existing black box warning on antidepressants’ labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment, proposed by US FDA.
According to a new brain study, even people who seemed resilient but were close to the World Trade Center when the twin towers toppled on Sept. 11, 2001, have brains that are more reactive to emotional stimuli than those who were more than 200 miles away.
It?s only natural to for adults to worry about children?s health and well-being at school, on the roads and even online. But adults? No. 1 health concern for children and adolescents in the United States? It?s smoking, according to new results from the University of Michigan C.S. Mott Children?s Hospital National Poll on Children?s Health. Drug abuse ranked No. 2.
The U.S. Food and Drug Administration (FDA) proposed that makers of all antidepressant medications update the existing black box warning on their products’ labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment (generally the first one to two months).